Kidney drug study: how does BPN14770 affect patients?
NCT ID NCT07012005
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looked at how the drug BPN14770 is processed by the body in people with severe kidney impairment compared to healthy volunteers. Fourteen participants took a single dose, and researchers measured drug levels and checked for side effects. The goal was to understand if kidney function changes how the drug works, not to treat the kidney disease itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Division of Clinical Pharmacology, University of Miami
Miami, Florida, 33136, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.